Vaccine Info

PedvaxHIB Vaccine

Authored by

PedvaxHIB Description 2022

PedvaxHIB is a sterile product formulated to contain: 7.5 mcg of Haemophilus b PRP, 125 mcg of Neisseria meningitidis OMPC and 225 mcg of aluminum as amorphous aluminum hydroxyphosphate sulfate 

PedvaxHIB Indication

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age. PedvaxHIB should not be used in infants <6 weeks of age.

PedvaxHIB Dosage

Age (months)      at First DosePrimaryAge (months)      at Booster    DoseDose

2 to 10                   2 doses, 2 months apart                    12 to 15          0.5 mL

11 to 14                 2 doses, 2 months apart                       —                 0.5 mL

15 to 71                 1 dose                                                  —                 0.5 mL

Clinical Trials

No clinical trials found